Immediate Impact
6 from Science/Nature 74 standout
Citing Papers
New promises and challenges in the treatment of advanced non-small-cell lung cancer
2024 Standout
Theranostic Fluorescent Probes
2024 Standout
Works of Shevan Silva being referenced
Abstract 5358: The hypoxia-activated EGFR-TKI TH-4000 overcomes erlotinib-resistance in preclinical NSCLC models at plasma levels achieved in a Phase 1 clinical trial
2015
Abstract A66: Preclinical rationale for the ongoing Phase 2 study of the hypoxia-activated EGFR-TKI tarloxotinib bromide (TH-4000) in patients with advanced squamous cell carcinoma of the head and neck (SCCHN) or skin (SCCS)
2015
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Shevan Silva | 73 | 154 | 68 | 144 | 136 | 17 | 350 | |
| Bertrand Heckmann | 43 | 57 | 42 | 229 | 98 | 16 | 392 | |
| Antonio Serafín | 66 | 85 | 17 | 166 | 108 | 34 | 337 | |
| Daniel P. Camarco | 50 | 51 | 28 | 155 | 123 | 21 | 404 | |
| Andrea L. Merz | 62 | 41 | 51 | 193 | 114 | 14 | 376 | |
| Nicole Willemsen‐Seegers | 46 | 47 | 61 | 226 | 97 | 18 | 358 | |
| Lori Rice | 73 | 59 | 23 | 152 | 72 | 20 | 366 | |
| Kazuhisa Minamiguchi | 71 | 53 | 56 | 142 | 38 | 25 | 394 | |
| E Tweedle | 37 | 106 | 43 | 169 | 204 | 11 | 387 | |
| Brigitte Simon | 113 | 51 | 22 | 193 | 104 | 19 | 411 | |
| Megumi Morimoto | 63 | 82 | 26 | 172 | 46 | 18 | 356 |
All Works
Login with ORCID to disown or claim papers
Loading papers...